PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism
about
PI3Kγ in hypertension: a novel therapeutic target controlling vascular myogenic tone and target organ damageThe Multifaceted Roles of PI3Kγ in Hypertension, Vascular Biology, and InflammationRenal autoregulation in health and diseaseCentral Role of P2Y6 UDP Receptor in Arteriolar Myogenic ToneGenetic Analysis Reveals a Longevity-Associated Protein Modulating Endothelial Function and Angiogenesis.Stretch-sensitive down-regulation of the miR-144/451 cluster in vascular smooth muscle and its role in AMP-activated protein kinase signalingRedox signaling via oxidative inactivation of PTEN modulates pressure-dependent myogenic tone in rat middle cerebral arteriesExpression of microRNAs is essential for arterial myogenic tone and pressure-induced activation of the PI3-kinase/Akt pathway.Mural propagation of descending vasa recta responses to mechanical stimulationThe prosurvival protein BAG3: a new participant in vascular homeostasisTherapeutic applications of PI3K inhibitors in cardiovascular diseases.Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase.Long non-coding RNA MT1DP shunts the cellular defense to cytotoxicity through crosstalk with MT1H and RhoC in cadmium stress.Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.Morus alba extract modulates blood pressure homeostasis through eNOS signaling.
P2860
Q27026365-F77EC7E2-5B87-4E63-9A64-6BCE658855FDQ28066576-45D9A4A9-D00E-48EE-BAAA-0CB671428C3AQ28082365-14195C03-FC49-4F94-AB0B-4E8F0119F0EEQ30276681-FE192D0F-8B5E-4E0D-83A2-F5ABB2D34625Q33870888-A9552BCA-4F71-47D0-A57F-851E5ABB4385Q34738318-500C0F41-132B-41C1-B726-489F8F65EE86Q34827639-8595BEB3-3AF8-49FB-9000-97C271AD0277Q35043317-CCB3FBAF-C596-4CA1-8146-FF80D65B1A76Q37093686-FB337067-C8A5-4F1D-AEE3-B9C2F73DA0A0Q37465928-5A94477B-1883-444B-8A6F-C097C5ACF01BQ38089742-48AE10CB-D602-4203-A7A7-95F2DEED2AE6Q39195631-A0D69DFA-6B48-4912-9727-CC9EC2C3F008Q50146306-7996C525-448E-4747-9E72-0D45166CD58CQ52366309-A310A7F0-EC37-4F34-877B-22D717A17F1EQ52626797-BD1CA648-00AD-4E10-81BC-B156E32ADBFEQ54192529-C7C590F4-690B-4652-85F7-5A4AB0887494
P2860
PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism
description
im Oktober 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 27 October 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2011
@uk
name
PI3Kγ inhibition reduces blood ...... type calcium channel mechanism
@en
PI3Kγ inhibition reduces blood ...... type calcium channel mechanism
@nl
type
label
PI3Kγ inhibition reduces blood ...... type calcium channel mechanism
@en
PI3Kγ inhibition reduces blood ...... type calcium channel mechanism
@nl
prefLabel
PI3Kγ inhibition reduces blood ...... type calcium channel mechanism
@en
PI3Kγ inhibition reduces blood ...... type calcium channel mechanism
@nl
P2093
P2860
P50
P356
P1476
PI3Kγ inhibition reduces blood ...... type calcium channel mechanism
@en
P2093
Alessandro Landolfi
Elio Franco
Giovanni Esposito
Giulio Selvetella
Hannelore Haase
Orazio Mazzoni
Paolo Grieco
P2860
P304
P356
10.1093/CVR/CVR288
P50
P577
2011-10-27T00:00:00Z